Tien Liang Biotech Co., Ltd. (4127) Stock Price & Analysis
4127 Stock Chart & Stats
- Day’s Range
- TWD 31.45 - TWD 34.00
- 52-Week Range
- TWD 29.00 - TWD 96.00
- Previous Close
- TWD 34.55
- Volume
- N/A
- Average Volume (3M)
- 218.75K
- Market Cap
- TWD 1.51B
- Enterprise Value
- TWD 2.03B
- Total Cash (Recent Filing)
- TWD 197.10M
- Total Debt (Recent Filing)
- TWD 598.00M
- Price to Earnings (P/E)
- 22.4
- Beta
- 0.32
- Next Earnings
- Nov 12, 2026 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Aug 27, 2024
- Dividend Yield
- N/A
4127 FAQ
What was Tien Liang Biotech Co., Ltd.’s price range in the past 12 months?
What is Tien Liang Biotech Co., Ltd.’s market cap?
When is Tien Liang Biotech Co., Ltd.’s upcoming earnings report date?
How were Tien Liang Biotech Co., Ltd.’s earnings last quarter?
Is Tien Liang Biotech Co., Ltd. overvalued?
Does Tien Liang Biotech Co., Ltd. pay dividends?
What is Tien Liang Biotech Co., Ltd.’s EPS estimate?
How many shares outstanding does Tien Liang Biotech Co., Ltd. have?
What happened to Tien Liang Biotech Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Tien Liang Biotech Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Tien Liang Biotech Co., Ltd.
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Junxiong Guo
- Employees
- 88
- Website
- www.tlb.com.tw
- Address
- TW
Tien Liang Biotech Co., Ltd. (4127) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 4 | 2 | 16 |
| Technical Analysis | 4 | 2 | 4 |
| Moving Averages | 0 | 0 | 12 |

